PYXS - Pyxis Oncology Inc
IEX Last Trade
3.78
0.120 3.175%
Share volume: 300,826
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.66
0.12
3.28%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
2.16%
1 Month
-1.56%
3 Months
1.88%
6 Months
-40.41%
1 Year
79.62%
2 Year
45.21%
Key data
Stock price
$3.78
DAY RANGE
N/A - N/A
52 WEEK RANGE
$1.35 - $6.85
52 WEEK CHANGE
$0.63
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website: pyxisoncology.com
Employees: 70
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: pyxisoncology.com
Employees: 70
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
pyxis oncology is developing antibody therapeutics to promote the body's immune response to cancer, based on new insights into the tumor micro-environment.
Recent news